Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Norwegian Intensive Care Unit Dalteparin Effect Study

NCT01721928 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01721928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01721928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Norwegian Intensive Care Unit Dalteparin Effect Study
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Completed
Start date
December 3, 2012
Completion date
March 1, 2017
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, deep venous thrombosis